All Stories

  1. Tracking Decitabine Incorporation into Malignant Myeloid Cell DNA in vitro and in vivo by LC-MS/MS with Enzymatic Digestion
  2. Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates
  3. Tramadol (opioid) abuse is associated with a dose- and time-dependent poor sperm quality and hyperprolactinaemia in young men
  4. Epidemiology of dermatophyte infections among school children in Menoufia Governorate, Egypt
  5. Origins of myelodysplastic syndromes after aplastic anemia
  6. Comparison of intrathecal versus intra-articular dexmedetomidine as an adjuvant to bupivacaine on postoperative pain following knee arthroscopy: a randomized clinical trial
  7. IL-8 mRNA and Serum Levels in Vitiligo Patients: A Case Control Study
  8. Recurrent genetic defects on chromosome 5q in myeloid neoplasms
  9. DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
  10. Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes
  11. Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts
  12. Non-apoptotic Sperm Selection
  13. Ligand exchange on gold nanoparticles for drug delivery and enhanced therapeutic index evaluated in acute myeloid leukemia models
  14. Runx1 Regulation of Pu.1 Corepressor/Coactivator Exchange Identifies Specific Molecular Targets for Leukemia Differentiation Therapy
  15. Ribosomal S6 Kinase and AKT Phosphorylation as Pharmacodynamic Biomarkers in Patients With Myelodysplastic Syndrome Treated With RAD001
  16. Gender, Cytidine Deaminase, and 5-Aza/Decitabine--Response
  17. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies
  18. Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy
  19. High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects
  20. Relationship of semen contents and sperm chromatin
  21. Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine
  22. A comprehensive work up for an asthenozoospermic man with repeated intracytoplasmic sperm injection (ICSI) failure
  23. A red palm oil diet can reduce the effects of oxidative stress on rat spermatozoa
  24. p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia
  25. Association of sperm morphology and the sperm deformity index (SDI) with poly (ADP-ribose) polymerase (PARP) cleavage inhibition
  26. TUNEL as a Test for Sperm DNA Damage in the Evaluation of Male Infertility
  27. Semen characteristics and sperm DNA fragmentation in infertile men with low and high levels of seminal reactive oxygen species
  28. Histopathologic patterns of testicular biopsies in infertile azoospermic men with varicocele
  29. Relationship of reactive oxygen species levels in day 3 culture media to the outcome of in vitro fertilization/intracytoplasmic sperm injection cycles
  30. Reactive oxygen species levels are independent of sperm concentration, motility, and abstinence in a normal, healthy, proven fertile man: a longitudinal study
  31. Decitabine Maintains Hematopoietic Precursor Self-Renewal by Preventing Repression of Stem Cell Genes by a Differentiation-Inducing Stimulus
  32. Single Nucleotide Polymorphism (SNP) of the Endothelial Nitric Oxide Synthase (eNOS) Gene (Glu298Asp Variant) in Infertile Men With Asthenozoospermia
  33. 1931 PRETREATMENT SPERM DNA FRAGMENTATION INDEX (DFI) IN CANCER PATIENTS AND ITS RELATIONSHIP TO POSTCRYOPRESERVATION MOTILE SPERM CONCENTRATION (PCMSC) AND SPERM MOTILITY (PCSM)
  34. The association between leukocytes and sperm quality is concentration dependent
  35. Sperm viability, apoptosis, and intracellular reactive oxygen species levels in human spermatozoa before and after induction of oxidative stress
  36. Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes
  37. Evaluation of chemiluminescence and flow cytometry as tools in assessing production of hydrogen peroxide and superoxide anion in human spermatozoa
  38. Reply of the Authors: Methods for defecting sperm apoptosis
  39. Evaluation of poly(ADP-ribose) polymerase cleavage (cPARP) in ejaculated human sperm fractions after induction of apoptosis
  40. Association of sperm apoptosis and DNA ploidy with sperm chromatin quality in human spermatozoa
  41. Determination of Poly (ADP-ribose) polymerase (PARP) homologues in human ejaculated sperm and its correlation with sperm maturation
  42. Diagnostic value of the total antioxidant capacity (TAC) in human seminal plasma
  43. L-Carnitine decreases DNA damage and improves the in vitro blastocyst development rate in mouse embryos
  44. DEFINING REFERENCE VALUES FOR SEMINAL REACTIVE OXYGEN SPECIES (ROS) IN A POPULATION OF INFERTILE MEN USING RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE
  45. PRESENCE AND POSSIBLE ROLE OF POLY (ADP-RIBOSE) POLYMERASE (PARP) HOMOLOGUES IN EJACULATED HUMAN SPERMATOZOA
  46. Assessment of anti-mullerian hormone (AMH) levels in prepubertal children undergoing gonadotoxic chemotherapy: a potential gonadal reserve marker